A joint US-Dutch team under the direction of Anita Mahadevan-Jansen, Vanderbilt University, US, has developed a non-invasive probe capable of both morphological and biochemical characterisation of skin cancers. The portable instrument combines a Raman spectroscopy (RS) system with an Optical Coherence Tomography (OCT) device and enables sequential acquisition of co-registered OCT and RS data sets. An Andor high resolution, near-infrared-enhanced Newton camera was chosen as the core element of the Raman diagnosis module.
The probe will screen large areas of skin up to 15mm wide to a depth of 2.4mm with OCT to visualise microstructural irregularities and perform an initial morphological analysis of lesions. The OCT images are then used to identify locations to acquire biochemically specific Raman spectra.
'Due to the inherently weak nature of Raman scattering and the relatively intense background auto-fluorescence from tissue, collection efficiency is a critical factor in the design of clinical RS probes,' said Chetan Patil, Vanderbilt University, US. 'Unlike confocal approaches that emphasise axial resolution, our probe is designed to prioritise collection efficiency. The high sensitivity of the Andor Newton CCD’s back-illuminated, deep-depletion, thermo-electrically cooled design is well suited to the stringent demands of in vivo Raman spectroscopy.
'Having demonstrated the clinical potential of the RS-OCT instrument to rapidly screen at risk patients, we are continuing to develop the dual-modal technique for other applications where non-invasive assessment of both microstructure and biochemical composition are critical to accurate assessment of pathology. The LabView software development kit, which is supplied with the camera and supported directly by Andor, was crucial in the development of our first probe and in our on-going research,' continued Patil.
According to Antoine Varagnat, product specialist at Andor: 'With its high sensitivity in the NIR enabled by high Quantum Efficiency and deep TE-cooling interface, the Newton Deep-Depletion CCD platform is just the right detector for demanding clinical NIR spectral diagnosis. One also gets the benefit of long-lasting detection performance and reliability with Andor’s UltraVac vacuum technology, alongside high speed acquisitions and ease of integration.'
Andor’s modular spectroscopy solutions encompass a wide range of high performance CCD, ICCD, EMCCD and InGaAs array detectors, as well as a comprehensive range of research-grade spectrograph platforms.
